Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? (Q43281624)

18 November 2017

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? (English)

1 reference

18 November 2017

1 reference

1 reference

F K Knop

1

1 reference

18 November 2017

1 September 2009

1 reference

18 November 2017

1 reference

18 November 2017

52

1 reference

18 November 2017

11

1 reference

18 November 2017

2270-2276

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-009-1511-8

18 November 2017

0 references

cites work

Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-009-1511-8

21 January 2018

1 reference

12 December 2020

Abnormal pancreatic alpha-cell function in first-degree relatives of known diabetics

1 reference

12 December 2020

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus

1 reference

12 December 2020

The mechanisms of surgical treatment of type 2 diabetes

1 reference

12 December 2020

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

1 reference

12 December 2020

Etiology of type II diabetes mellitus: role of the foregut

1 reference

12 December 2020

Glucagon and the A cell: physiology and pathophysiology (second of two parts)

1 reference

12 December 2020

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

1 reference

12 December 2020

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

1 reference

12 December 2020

Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans

1 reference

12 December 2020

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

12 December 2020

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

1 reference

12 December 2020

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

12 December 2020

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

1 reference

12 December 2020

The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP)

1 reference

12 December 2020

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

1 reference

12 December 2020

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

1 reference

12 December 2020

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

1 reference

12 December 2020

Potential of surgery for curing type 2 diabetes mellitus

1 reference

12 December 2020

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

1 reference

12 December 2020

Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line

1 reference

12 December 2020

Biology of incretins: GLP-1 and GIP

1 reference

12 December 2020

A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?

1 reference

12 December 2020

Extrapancreatic Glucagons

1 reference

12 December 2020

Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications.

1 reference

12 December 2020

Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery

1 reference

12 December 2020

The Physiology of Glucagon-like Peptide 1

1 reference

12 December 2020

Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.

1 reference

12 December 2020

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

12 December 2020

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

1 reference

12 December 2020

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

1 reference

12 December 2020

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

1 reference

12 December 2020

Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass.

1 reference

12 December 2020

Exon duplication and divergence in the human preproglucagon gene

1 reference

12 December 2020

Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

1 reference

12 December 2020

Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.

1 reference

12 December 2020

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats

1 reference

12 December 2020

Circulating glucagon after total pancreatectomy in man

1 reference

12 December 2020

Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects

1 reference

12 December 2020

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

1 reference

12 December 2020

Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans

1 reference

12 December 2020

Role of prohormone convertases in the tissue-specific processing of proglucagon

1 reference

12 December 2020

Reduced Incretin Effect in Type 2 Diabetes

1 reference

12 December 2020

The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.

1 reference

12 December 2020

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

1 reference

12 December 2020

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

12 December 2020

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

12 December 2020

10.1007/S00125-009-1511-8

Identifiers

DOI

1 reference

18 November 2017

1 reference

PubMed ID

19727661